Equities research analysts at StockNews.com began coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research note issued to investors on Monday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Down 10.3 % NASDAQ:EGRX opened at $0.52 on Monday. The stock’s fifty day moving […]

Stock analysts at StockNews.com started coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on the stock. LADENBURG THALM/SH SH began coverage on […]